All data are based on the daily closing price as of October 8, 2025
b

Boryung

003850.KO
6.13 USD
-0.14
-2.23%

Overview

Last close
6.13 usd
Market cap
517.89M usd
52 week high
9.22 usd
52 week low
5.24 usd
Target price
10.52 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.7114
Price/Book Value
0.9279
Enterprise Value
584.12M usd
EV/Revenue
0.8164
EV/EBITDA
9.9028

Key financials

Revenue TTM
715.47M usd
Gross Profit TTM
255.19M usd
EBITDA TTM
79.02M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
975.33M usd
Net debt
146.55M usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top